strains of Escherichia coli and Klebsiella pneumoniae that caused septicemia likely originated from the gut. 2 The relationship between the gut microbiota and development of viral infections, however, is not well described. Studies in mice have shown a relationship between the gut microbiota and impaired viral clearance. Abt et al investigated antibiotic administration in a mouse model of lymphocytic choriomeningitis virus and found that antibiotic administration led to decreased innate viral immunity response as well as delayed clearance. 3 Further studies have revealed that butyrate, a product of certain gut anaerobic bacteria, can have an immunomodulatory role and contributes to overall health in distant sites such as the lung. 4 Haak et al investigated the role of butyrate-producing gut (BPG) bacteria on future development of viral infections. In a cohort of 360 allogeneic HSCT recipients, they reported that having a >1% relative gut abundance of BPG bacteria is associated with 5-fold less future development of lower respiratory viral infections. 5 Based upon this study, we profiled the gut microbiota using 16S rRNA gene sequencing of the V4-V5 region in 510 fecal specimens from 168 kidney transplant recipients. We report that having a >1% relative abundance of BPG bacteria is associated with less risk for development of respiratory viral infections in kidney transplant recipients, which provides further support for the findings from the Haak et al study. 5 
| PATIENTS AND ME THODS

| Kidney transplant cohort
From August 2015 to November 2016, 280 kidney transplant recipients were consented for serial collection of fecal specimens, and 168 kidney transplant recipients provided at least one fecal specimen for gut microbial profiling. Among the 168 kidney transplant recipients, 121 subjects provided a fecal specimen at post-transplant week 2 (between post-operative day 8 and post-operative day 24); 162 subjects provided at least one fecal specimen in the first 30 days after transplantation for the pooled individual mean analysis. Demographics and clinical characteristics were collected from chart review. The study was approved by the Weill Cornell Institutional Review Board, and all subjects provided written informed consent.
| Fecal specimen collections
Kidney transplant recipients provided fecal specimens using the Fisherbrand ™ commode specimen collection kit (Thermo Fisher Science). Fecal specimens were aliquoted into approximately 200 mg aliquots and subsequently stored at −80°C. The recipients were asked to provide the specimens at post-transplant week 1, 2, 4, and 12.
| 16S rRNA gene amplification and sequencing
DNA extraction and 16S rRNA gene amplification of the 16S rRNA gene V4-V5 region (563F and 926R) were performed as described in Lee et al. 6 Sequencing of the PCR amplicons was performed on an Illumina MiSeq platform (250 base pair × 250 base pair).
| Bioinformatics and taxonomic classification
Bioinformatics and taxonomic classification were performed as described in Lee et al. 6 Briefly, taxonomy was determined using nucleotide BLAST 7 with the reference training set, NCBI RefSeq 8 and a minimum E-value threshold of 1 × 10 −10 .
| Viral infection monitoring and definitions
Respiratory virus infections, CMV viremia, and BK viremia were determined by review of electronic medical records of each sub- 
| Statistical analyses
The distribution of continuous variables was analyzed using the twotailed Wilcoxon rank-sum test for unpaired values and the two-tailed Wilcoxon signed-rank test for paired values; the distribution of categorical variables was analyzed using two-tailed Fisher's exact test.
A Cox Regression Hazard Model was used to estimate whether a relative gut abundance of BPG bacteria was associated with a decreased risk for development of respiratory virus infections, CMV viremia, or BK viremia. Survival curves were constructed and compared using the log-rank test. All analyses were performed in R 3.3.3
in RStudio 1.1.463.
| RE SULTS
| Top butyrate-producing gut bacteria in the cohort
Among the 510 fecal specimens from the 168 kidney transplant recipients, the mean ± standard deviation amount of high quality 16S
rRNA bacterial gene sequences was 18 179 ± 11 033. The overall demographics and transplant characteristics of these subjects are presented in Table 1 . Out of the 61 BPG species, 40 species were detected (Table S1 ). The sum relative gut abundance of BPG bacteria was calculated for each fecal specimen (defined hereafter as relative gut abundance of BPG bacteria). The mean relative gut abundance of BPG bacteria among all of the 510 fecal specimens was 14.2% with a standard deviation of 13.1%. The top BPG species were:
Faecalibacterium prausnitzii (3.7%, mean), Holdemanella biformis (2.7%), Eubacterium dolichum (2.6%), Coprococcus comes (1.2%), Subdoligranulum variabile (0.8%), and Eubacterium rectale (0.7%). A heatmap of the relative gut abundance of these top species among all the fecal specimens is presented in Figure 1 . The relative abundance of each species is represented in blue, log-scaled. There is marked variability in the top butyrateproducing species among the specimens signed-rank test; Figure 2D ). We next evaluated the subgroup of subjects in the Paired Abx Group who received anaerobic antibiotic coverage. Anaerobic antibiotic coverage included the following antibiotics: metronidazole, carbapenems, clindamycin, combination of penicillin and beta-lactamase inhibitor, and oral vancomycin. 9, 10 The rationale for evaluating antibiotics with anaerobic coverage was based on the strict anaerobic nature of many of the BPG bacteria (eg, Faecalibacterium prausnitzii and Eubacterium rectale). 11 Among the Paired Abx Group, 6 subjects had anaerobic antibiotic coverage and all 6 had a significant decrease in the relative gut abundance of BPG bacteria from post-transplant week 1 to post-transplant week 4 (median 9.9% vs 1.9%, respectively, P = .03, Wilcoxon signed-rank test; Figure 2E ).
| Antibiotics and butyrate-producing gut bacteria over time in the cohort
We also evaluated whether the relative gut abundance of BPG bacteria was associated with gender, age greater than 65 years old, African American race, induction therapy, steroid maintenance therapy, and kidney function at 1 month post transplantation. As antibiotics are associated with decreased abundance of BPG bacteria, we evaluated the paired specimens from the 54 subjects who did not receive antibiotics from post-transplant week 1 and post-transplant
The abundance of butyrate-producing gut bacteria over time in the kidney transplant cohort. Panel A. Each point represents a single fecal specimen with the day the specimen was produced on the x-axis and the relative gut abundance of butyrate-producing gut (BPG) bacteria on the y-axis. The line represents a locally estimated scatterplot smoothing (LOESS) curve with 95% confidence intervals indicated by the shaded band. Panel B. Each point represents a single fecal specimen with the day the specimen was produced on the x-axis and the relative gut abundance of butyrate-producing gut (BPG) bacteria on the y-axis. A point in blue represents an individual fecal specimen from the 231 specimens from the 78 patients in the No Abx Group and a point in magenta represents an individual fecal specimen from the 279 specimens from the 90 patients in the Abx Group. The line represents a LOESS curve with 95% confidence intervals indicated by the shaded bands. Panel C. Box and whisker plot with the relative gut abundance of BPG bacteria on the y-axis and the fecal specimen posttransplant week on the x-axis for the 54 subjects in the Paired No Abx Group. In each box and whisker plot, the line represents the median, the edges of the box plot 25% and 75%, the whiskers 1.5 times the median, and points represent outliers. The P value was calculated using the Wilcoxon signed-rank test. Panel D. Box and whisker plot with the relative gut abundance of BPG bacteria on the y-axis and the fecal specimen post-transplant week on the x-axis for the 22 subjects in the Paired Abx Group. In each box and whisker plot, the line represents the median, the edges of the box plot 25% and 75%, the whiskers 1.5 times the median, and points represent outliers. The P value was calculated using the Wilcoxon signed-rank test. Panel E. Box and whisker plot with the relative gut abundance of BPG bacteria on the yaxis and the fecal specimen post-transplant week on the x-axis for the 6 subjects in the Paired Abx Group who received antibiotics with anaerobic coverage. In each box and whisker plot, the line represents the median, the edges of the box plot 25% and 75%, the whiskers 1.5 times the median, and points represent outliers. The P value was calculated using the Wilcoxon signed-rank test week 4 (Paired No Abx Group). The relative gut abundance of BPG bacteria was significantly lower in the female group than in the male group (median 11.4% vs 17.7%, P = .03, Wilcoxon rank-sum test; Figure S1A ) and significantly lower in the steroid maintenance group than in the in steroid free group (median 9.4% vs 17.6%, P = .01,
Wilcoxon rank-sum test; Figure S1E ). There were no significance associations between the relative gut abundance of BPG bacteria and age greater than 65 years old, African American race, induction therapy, and kidney function at 1 month post transplantation ( Figure   S1B -D,F).
| High butyrate-producing gut bacteria status and development of viral infections
We evaluated whether the relative gut abundance of BPG bacte- 
| D ISCUSS I ON
In this study, we report one of the first description of butyrate-producing gut bacteria over time in the kidney transplant population.
Our data reveal that antibiotics with anaerobic coverage is associated with a decrease in relative gut abundance of BPG bacteria. Our data also support a relationship between high relative gut abundance of BPG bacteria and less risk for development of respiratory It is important to note the allogeneic HSCT subjects had a much higher proportion of patients with a less than 1% relative gut abundance of BPG bacteria than the kidney transplant recipients in our study (81% vs. 8%, respectively). We speculate that this difference is likely because of the higher number of antibiotics given to the allogeneic HSCT population. In our study, we found that an- analyses. In addition, we used the cutoff of 1% relative gut abundance of BPG bacteria, which was utilized in the allogeneic HSCT recipient population. 5 Notably, there was a significance difference in the proportion of HSCT recipients and in the proportion of kidney transplant recipients with less than 1% relative gut abundance of BPG bacteria and whether this cutoff is also relevant for the kidney transplant population is unknown. In order to address this concern, we evaluated both a bottom quartile cutoff as well as a median cutoff and we did find an association between high relative gut abundance of BPG bacteria and decreased risk for respiratory viral infections using the bottom quartile cutoff. Another limitation is that respiratory viral panels were performed by clinicians on a for-cause indication basis unlike BK virus and CMV virus screening which was performed routinely per protocol. Not all subjects with respiratory viral symptoms were screened using the respiratory viral panels, which may have influenced our results. Furthermore, subjects may have asymptomatic long term respiratory viral infections prior to transplantation and whether our detection was the result of a new infection or asymptomatic colonization is not known.
We also note that our study evaluated upper respiratory viral in- 
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